S100A9 and Parkinson disease: Indeed, S100A9 is present in the neuronal cells and Lewy bodies in the substantia nigra, the region primarily affected by disease, and in the PD frontal lobe areas, which are affected by the disease at its later stages (Figs. 1, 2, and 4).